Global Hematopoietic Stem Cells Transplantation Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Hematopoietic Stem Cells Transplantation Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.

According to our (Global Info Research) latest study, the global Hematopoietic Stem Cells Transplantation market size was valued at US$ 2641 million in 2023 and is forecast to a readjusted size of USD 3843 million by 2030 with a CAGR of 5.6% during review period.

Market competition is intense. CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Top 5 players accounted for about 32.09% market share.

This report is a detailed and comprehensive analysis for global Hematopoietic Stem Cells Transplantation market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Hematopoietic Stem Cells Transplantation market size and forecasts, in consumption value ($ Million), 2019-2030

Global Hematopoietic Stem Cells Transplantation market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Hematopoietic Stem Cells Transplantation market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Hematopoietic Stem Cells Transplantation market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Hematopoietic Stem Cells Transplantation

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Hematopoietic Stem Cells Transplantation market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies, Vcanbio, Merck Millipore, Lonza Group, CellGenix Technologie Transfer, ThermoGenesis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Hematopoietic Stem Cells Transplantation market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Hematopoietic Stem Cells Transplantation market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Stem Cells Storage
Stem Cells Consumables

Market segment by Application
Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders

Market segment by players, this report covers
CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Hematopoietic Stem Cells Transplantation product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Hematopoietic Stem Cells Transplantation, with revenue, gross margin, and global market share of Hematopoietic Stem Cells Transplantation from 2019 to 2024.

Chapter 3, the Hematopoietic Stem Cells Transplantation competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Hematopoietic Stem Cells Transplantation market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Hematopoietic Stem Cells Transplantation.

Chapter 13, to describe Hematopoietic Stem Cells Transplantation research findings and conclusion.